PLOD1 and obesity due to melanocortin 4 receptor deficiency: In conclusion, present research provides a high translational value preclinical evidence for the feasibility of LH chemogenetic modulation as a tool for CNS-targeted chemogenetic drug discovery, and simultaneously, it delivers the first translatable indirect in vivo POC for the therapeutic feasibility of chemogenetics in obesity indication.